25.10.2013 Views

Implementation Guidelines - Federal Transit Administration - U.S. ...

Implementation Guidelines - Federal Transit Administration - U.S. ...

Implementation Guidelines - Federal Transit Administration - U.S. ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

MRO is not required to direct the<br />

analysis of the split specimen to be<br />

performed.<br />

• The MRO must maintain all<br />

necessary records and protect the<br />

employee’s privacy and testing<br />

program confidentiality.<br />

The MRO must confirm a positive test<br />

result for marijuana, cocaine, amphetamines,<br />

and/or phencyclidine unless the employee<br />

presents a legitimate medical explanation for<br />

the presence of the drug/metabolite in<br />

his/her system. The burden of proof is on<br />

the employee to provide necessary<br />

documentation of the medical explanation.<br />

This information must be presented at the<br />

time of the verification interview with the<br />

MRO. If a valid medical explanation is<br />

provided, the MRO must verify and report<br />

the test as negative. If not, the MRO must<br />

verify and report the test result as positive.<br />

If the laboratory reports a positive test<br />

result for opiates, the MRO must review the<br />

laboratory results to determine if 6acetylmorphine<br />

(6-AM) was present in the<br />

specimen: if so, the test must be verified<br />

positive. If 6-AM is not present, but the<br />

codeine or morphine levels are above 15,000<br />

ng/mL, the burden of proof is on the<br />

employee to provide documentation of a<br />

legitimate medical explanation. If the<br />

concentrations are less than 15,000 ng/mL,<br />

the burden of proof is on the MRO to<br />

determine if there is clinical evidence of<br />

illegal drug use. To accomplish this task,<br />

the MRO must conduct or require another<br />

physician to conduct a face-to-face<br />

examination of the employee. If no clinical<br />

evidence is found, the MRO must verify the<br />

test result as negative.<br />

If a specimen is determined by the<br />

laboratory to be adulterated or substituted,<br />

the MRO will provide the employee with the<br />

same opportunity to explain the test result as<br />

if it were positive. Thus, the MRO should<br />

explain the test results to the employee and<br />

offer the employee the opportunity to<br />

present a legitimate medical explanation for<br />

the laboratory validity, or adulterant test<br />

result. In the case of an adulterated<br />

specimen, the employee has the burden of<br />

proof to demonstrate that the adulterant<br />

entered the specimen through physiological<br />

means. In the case of a substituted<br />

specimen, the employee must demonstrate<br />

that he/she can produce a urine specimen<br />

through physiological means that has<br />

creatinine and specific gravity levels that fall<br />

within the criteria of a substitute specimen.<br />

If the explanation appears reasonable,<br />

the employee will have up to 5 days to<br />

undergo a medical examination by a<br />

qualified medical physician, acceptable to<br />

the MRO, to evaluate and consider any<br />

evidence that the employee presents. The<br />

evidence must be gathered using appropriate<br />

methodology and controls to ensure its<br />

accuracy and reliability. The employee<br />

must demonstrate that the cited medical<br />

condition actually results in the<br />

physiological production of urine meeting<br />

the creatinine and specific gravity criteria.<br />

Chapter 7. Drug Testing Procedures 7-22 August 2002

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!